Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Multi-institutional Phase III Trial of Salvage Systemic Therapy With or Without Stereotactic Ablative Radiotherapy for Recurrent Ovarian Cancer

NCT05444270 is registered in ClinicalTrials.gov with Yonsei University as lead sponsor.

NCT NCT05444270
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05444270 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Multi-institutional Phase III Trial of Salvage Systemic Therapy With or Without Stereotactic Ablative Radiotherapy for Recurrent Ovarian Cancer
Lead sponsor
Yonsei University
Phase
Not applicable
Overall status
Recruiting
Start date
October 26, 2022
Completion date
December 31, 2026
Enrollment
270 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

recurrent epithelial ovarian cancer